Supplementary Table from Tucatinib has Selective Activity in HER2-Positive Cancers and Significant Combined Activity with Approved and Novel Breast Cancer–Targeted Therapies

Autor: Dennis J. Slamon, Jun Zhang, Ming Lu, Ke Wei Gong, Shawnt Issakhanian, Raul Ayala, Tong Luo, Athena M. Madrid, Martina S.J. McDermott, Holly K.T. Huang, Neil A. O'Brien
Rok vydání: 2023
Popis: Supplementary Table from Tucatinib has Selective Activity in HER2-Positive Cancers and Significant Combined Activity with Approved and Novel Breast Cancer–Targeted Therapies
Databáze: OpenAIRE